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ABSTRACT  
 
Alternative forms of proinsulin mRNA with differential translational capacities and 
unknown significance are expressed in several developing tissues and in the adult 
pancreas. In the chick embryo developing heart, we observed low expression of the 
translationally active transcript of embryonic proinsulin (Pro1B), and predominant 
expression of the intron 1-unspliced variant, translationally inactive. In the embryonic 
mouse heart, intron 1-unspliced isoform appeared after E12.5. This tight regulation is 
required for normal development, since overexpression of Pro1B resulted in abnormal 
cardiac morphogenesis in 40% of chick embryos, and was accompanied by changes in 
gene expression of Amhc1and Vmhc1. 
 
Keywords: Proinsulin, insulin gene, alternative splicing, intron retention, 
cardiogenesis, cardiac malformations.  
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1. Introduction 
 
In mammalian organisms, insulin, secreted mainly by the pancreas, acts as an 
anabolic hormone after birth, maintaining glucose homeostasis. In the last two decades, 
other developmental functions of insulin, its precursor proinsulin, and insulin-like 
peptides have emerged in vertebrates and invertebrates [1-3]. Moreover, extrapancreatic 
proinsulin mRNA expression and alternative mechanisms of postranscriptional 
regulation have been reported [4-8]. We previously characterized insulin gene 
expression in the chick embryo during early stages of development, prior to 
differentiation of the pancreas [3]. Prepancreatic proinsulin remains unprocessed [9] and 
its tissue levels are finely regulated through the expression of transcript variants (Fig. 
1A) that differ in their translational activity [4, 5]. In the prepancreatic embryo, insulin 
gene transcription begins 32 nucleotides (nt) 5’ upstream of the pancreatic transcription 
start site, generating a proinsulin transcript (Pro1B) with an extension of 32 nt in its 5’ 
untranslated region (5’UTR). This transcript variant has lower translational activity than 
the pancreatic isoform (Pro1A) due to the presence of two upstream open reading 
frames [4]. An additional isoform, generated by the retention of intron 1 in the 
embryonic Pro1B transcript, is found in the prepancreatic embryo. The intron 1-
containing transcript (Pro1B1) has a much longer 5’UTR (extra 717-nt) that largely 
blocks its translational activity [5]. In the human adult pancreatic islet, a partially-
spliced intron 1 isoform with higher translational activity has been described [6]. Low 
levels of the intron 1-retained isoform have also been reported in the adult mouse 
pancreas, although with higher translational activity than the spliced isoform [8]. These 
observations indicate that intron 1 retention has differential effects on proinsulin 
biosynthesis in different species, and may respond to distinct functional requirements at 
the level of the tissue or organism.  
In the chick embryo, tight regulation of proinsulin expression appears to be 
essential for normal neural tube formation. Treatment of the embryo during closure of 
the neural tube with proinsulin antisense oligonucleotides increased the proportion of 
apoptotic cells in the rostral part of the embryo, indicating that a physiological function 
of proinsulin is to regulate cell survival/death during neurulation [9].  Information is 
lacking on the consequences of alternative transcripts expression or abnormal proinsulin 
expression in other developing tissues. The expression of proinsulin transcripts changes 
during early cardiogenesis in chicks; in the precardiac region only the fully-processed 
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mRNA (Pro1B) is detected, while the intron 1-containing transcript (Pro1B1) is 
expressed upon fusion of the heart tubes [5]. The aim of the present study was to 
analyze the expression of proinsulin embryonic transcripts during later stages of cardiac 
morphogenesis in mouse and chick. In addition, we evaluated the pathophysiological 
consequences of overexpression of translationally active variants, which increased 
proinsulin exposure in chick during cardiac development. We found that mRNA 
expression of proinsulin1 isoforms in the heart was developmentally regulated in both 
species. Moreover, the induction of inappropriately high proinsulin levels during 
cardiac morphogenesis in chick, resulted in major cardiac malformations. These 
alterations were paralleled by abnormal expression of atrial and ventricular myosine 
genes. 
   
 
2. Materials and Methods  
See Supplementary Data for full methods 
2.1. Embryos and plasmid electroporation  
All protocols for animal experiments were in accordance with EU guidelines for 
animal research and were approved by the CIB bioethics committee. Fertilized chicken 
eggs (Granja Santa Isabel, Córdoba, Spain) were incubated at 38ºC in forced-draft, 
humidified incubators. Mouse embryos (C57BL/6 and CD1) were removed from the 
uterus of pregnant females. The day of detection of the vaginal plug was designated as 
embryonic day (E) 0.5.  
For gain-of-function experiments, stage 3 cultured chick embryos were injected 
with pCAGs-I-GFP (control),  pCAGs-Pro1A-I-GFP or pCAGs-Pro1B-I-GFP in the 
region committed to form the heart and electroporated as described previously [10].  
 
2.2. Whole-mount ISH, RNA isolation, PCR and Western Blot 
All were performed following standard procedures. Specific modifications used and 
primer sequences are provided in Supplementary Data. 
 
2.3. Plasmids 
pCAGs-Pro1B-I-GFP, pCAGs-Pro1BV5-I-GFP, pCAGs-Pro1A-I-GFP and 
pCAGs-Pro1AV5-I-GFP were generated by excising the corresponding proinsulin 
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cDNA from previously described constructs [5] and cloning them into the pCAGs-I-
GFP [10]. 
 
3. Results  
 
3.1. Regulated expression of proinsulin transcript variants during cardiogenesis. 
Two embryonic proinsulin mRNA variants were previously shown to be dynamically 
regulated in the initial stages of cardiogenesis in the chick embryo, prior to pancreatic 
development [5]. The fully processed, translationally active, transcript was the 
predominant variant during specification of the cardiac fields. The percentage of intron 
1-unspliced, translationally inactive transcript, subsequently increased, peaking during 
the formation of the linear heart tube (stage 10), the final stage analyzed in that study 
[5]. Here, we further characterized proinsulin mRNA expression during heart 
morphogenesis, from the heart tube stage through to ventricular and atrial chamber 
formation (stages 10 to 20 for chicken and E8.5-13.5 for mouse, see Supp. Fig. 1). At 
each stage studied in the chick embryo, the predominant form of proinsulin mRNA was 
the intron 1-unspliced variant (Fig. 1A and B). One of the first morphogenetic events 
after heart tube formation is the establishment of the anterior-posterior polarity of the 
tube, exemplified by the progressive restriction of the expression of the ventricular and 
atrial myosine heavy chain genes (Vmhc1 and Amhc1) to the anterior and posterior 
portions of the heart tube, respectively [11]. We thus investigated whether the 
proinsulin transcript variants were preferentially distributed in the heart tube. The intron 
1-unspliced variant Pro1B1 represented ~90% of the total proinsulin transcripts in both 
the atrial (posterior) and ventricular (anterior) regions, indicating no difference between 
regions in the expression of Pro1B1 at this stage (Fig. 1C). 
Analysis of proinsulin expression in equivalent cardiac developmental stages in the 
mouse embryo revealed the presence of a single form of proinsulin mRNA from the 
earliest stage analyzed (E8.5, heart tube stage), corresponding to the fully spliced 
mRNA. An additional proinsulin transcript variant was detected from E12.5 onwards 
(Fig. 2B). The shortest molecular weight PCR band corresponded to the fully spliced 
isoform and the largest to the intron 1-unspliced isoform (all data confirmed by DNA 
sequencing). By contrast, in the developing mouse pancreas, at the level of sensitivity of 
semi-quantitative PCR, we only detected expression of the fully processed proinsulin 
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transcript (Fig. 2C). These results indicate that post-transcriptional regulation of heart 
proinsulin mRNA occurs during mouse cardiac morphogenesis, although at later 
developmental stages than in the chick.  
We next investigated the potentially deleterious effects of supraphysiological 
embryonic proinsulin in cardiogenesis in the chick embryo model. Before evaluating the 
embryonic phenotype, two constructs carrying a V5 tag were electroporated into 
gastrulating chick embryos (stage 3), and were tested for their ability to translate in vivo. 
Analysis of whole embryo protein extracts showed that these constructs gave rise to 
high (Pro1A) or moderate (Pro1B) levels of proinsulin (Fig. 3). Note that the molecular 
weight of the protein yield produced by the electroporated constructs corresponded to 
that of unprocessed proinsulin, as does the endogenously expressed protein at these 
embryo stages [9].  
 
3.2. Insulin receptor mRNA is expressed in the developing heart. We next analyzed 
the expression of insulin receptor (IR) as a potential mediator of proinsulin signaling. IR 
expression was detected in the developing heart in chick and mouse embryos at all ages 
studied (Fig. 4). One single band was PCR-amplified in chick, in agreement with our 
previous finding of only one IR isoform (corresponding to the IR-A isoform) in this 
species [12]. This semi-quantitative approach revealed IR expression at all ages tested, 
between stages 10 and 20 (Fig. 4A).  
In the embryonic mouse heart, both IR-A and IR-B isoforms were identified from 
E8.5 onwards, with the IR-A form increasing its expression slightly in the second half 
of gestation (Fig. 4B).These findings suggest that both the chick IR and mouse IR-A 
can mediate proinsulin signaling, as the IR-A isoform has been recently shown to bind 
proinsulin with high affinity and trigger intracellular signaling pathways upon 
autophosphorylation [13].  
 
3.3. Overexpression of proinsulin mRNA induces abnormal cardiac gene expression 
and morphogenesis. We previously demonstrated that while some proinsulin signaling 
is essential during early development, proinsulin overexpression is deleterious for 
neural tube development [9]. We thus analyzed the effect of supra-physiological levels 
of embryonic proinsulin on chick cardiogenesis. The two constructs producing high 
(Pro1A) and moderate (Pro1B) proinsulin levels were electroporated into gastrulating 
chick embryos and morphological evaluation was performed. Overexpression of Pro1A 
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and Pro1B induced cardiac malformations in different proportions of up to 61%, while 
only 8% of electroporated control embryos exhibited abnormalities (see Supp. Table 1). 
The malformations observed included cardia bifida, aberrant torsion and a “globular” 
aspect of the heart tube (Fig. 5A). Moreover, the severity of cardiac malformation was 
correlated with the translational activity of the transcripts. Whereas 38% of highly 
proinsulin expressing embryos (Pro1A-electroporated) showed absence of a beating 
heart formed, all of the moderately proinsulin expressing embryos (Pro1B-
electroporated) displayed a beating, although abnormal, heart tube (Supp. Table 1). 
Cardiac gene markers were visualized by in situ hybridization in control (GFP) 
and moderately high proinsulin expressing embryos. Significant changes in the 
expression of the atrial and ventricular chamber genes were observed. In embryos 
overexpressing Pro1B, Amhc1 expression was markedly decreased, while a concomitant 
increase in Vmhc1 expression was observed, which in some cases extended posteriorly 
(Fig. 5B). Embryos overexpressing Pro1A were excluded from the analysis as the 
severity of the malformations induced confounded analysis. A few embryos were 
sectioned and examined by optical microscopy (Fig. 5C). In the control embryos (GFP) 
there was a gradient in the expression of Amhc1 but all cells were positive. In contrast, 
Pro1B electroporated embryos had dramatically decreased expression and in some cases 
discontinuity in Amhc1 signal, with the negative cells located at the equator part of the 
tube in these horizontal sections (Fig. 5C). This “butterfly” image suggests either 
abnormal or absence of differentiation of a subset of precursors into cardiomyocytes. 
Our results thus show that, in the maternally-independent chick embryo model, supra-
physiological proinsulin levels during cardiogenesis (glucose-independent) alter the 
dynamic pattern of gene expression and impair cardiac chamber formation (Fig. 5). 
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4. Discussion 
In vertebrate organisms, insulin expression, regulation, active form and main 
function differ between developing and postnatal stages [for reviews see [1, 3]]. The 
postnatal pancreas abundantly expresses proinsulin mRNA and secretes mature insulin. 
The production and secretion of insulin is primarily regulated by glucose, and its main 
targets are metabolic tissues such as liver, muscle and fat. By contrast, prior to 
differentiation of the pancreas, proinsulin is the active protein form, and is produced in 
low abundance by several extrapancreatic tissues [9]. The expression of embryonic 
extrapancreatic proinsulin mRNA is independent of glucose levels, but depends on the 
presence of different transcript isoforms, which mediate distinct protein translation 
capabilities and tissue- and time-specific proinsulin availability [3]. The main aim of the 
present study was to characterize the alternative splicing pattern of proinsulin mRNA in 
the developing heart and determine the impact of inappropriately high proinsulin 
embryo exposure. In the chick embryo, the predominant proinsulin mRNA isoform 
detected during cardiac morphogenesis was the intron 1-unspliced transcript. This 
isoform is translationally inactive, suggesting that inactivation of proinsulin production 
is required during these stages of cardiac formation. Indeed, moderate increases in 
proinsulin levels induced by overexpression of the Pro1B proinsulin transcript 
dramatically interfered with the cardiac morphogenesis (see later). Here, we 
demonstrate that proinsulin production can be abrogated in the heart by regulating 
intron 1 processing, rather than completely switching off insulin gene expression. 
Previous studies have demonstrated that the splicing pattern of intron 1 is altered in 
response to growth factor deprivation, increasing proinsulin availability in the stressed 
embryo [5]. We thus speculate that maintenance of proinsulin gene in a transcriptionally 
active but translationally inactive state may represent a reversible back-up mechanism 
that allows embryonic tissues to adapt to environmental or developmental changes.  
The insulin gene is part of a phylogenetically conserved synteny formed by the 
tyrosine hydroxylase (Th), insulin and Igf2 genes. We previously demonstrated that 
unusual chimeric RNA transcripts are generated by Th and insulin genes during 
embryonic development, representing an additional post-transcriptional mechanism to 
regulate expression of the two adjacent genes [14]. Although the function of the 
chimeric RNA is unknown, alteration of TH levels in the chick embryo induces cardiac 
defects [10].  
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In mouse embryos, a proinsulin mRNA intron 1-containing isoform was observed 
at later stages of cardiac morphogenesis than in chicks. In contrast to the effects of 
intron 1-retention in chicks, the two alternative proinsulin transcripts generated in 
mammals by differential processing of intron 1 have been reported to display enhanced 
translational activities [6, 8]. Sequence and structural motifs in the UTR have a major 
impact on translational regulation [15, 16]. Among those 5’UTR structural features 
known to control translation, long and energetically stable secondary structures impair 
translation. Comparison of the secondary structure prediction for the 5’UTR of the 
chick fully-spliced (Pro1B) and intron 1-unspliced (Pro1B1) transcripts (Supp. Fig. 2) 
revealed a notable change in free energy (∆G = -29 to -256 Kcal/mol) due to intron 1 
retention, which includes a very long and stable stem-loop structure; thus this structural 
feature may account for the impaired proinsulin translation of the Pro1B1 mRNA. By 
contrast, mouse intron 1-retention resulted in a less stable stem-loop structure (change 
in free energy from ∆G= -5.5 to -37 Kcal/mol; Supp. Fig. 2), which appeared not to 
impair proinsulin translation.  
 
Interestingly, intron 1-containing proinsulin mRNA isoform is much more 
abundant in the heart than in the pancreas in embryonic stages. Indeed, we detected no 
expression of the intron 1-containing transcripts in the developing mouse pancreas at 
any of the stages analyzed, in agreement with our findings in the chick [5]. This result is 
compatible with the very low abundance of intron 1-unspliced transcript described in 
adult mouse and human pancreatic islets [6, 8]. Our findings thus support the functional 
significance of RNA processing in the fine tuned proinsulin regulation required during 
embryonic development. The differential effects of intron 1 retention on translational 
activity in chicks and mice may reflect the distinct proinsulin requirements of each 
species during cardiac development. 
The additional post-translational regulation specific to the pancreatic islets (i.e., 
cleavage of proinsulin into mature insulin) further differentiates the pancreatic hormone 
from the growth factor-like activity of extrapancreatic proinsulin. While an anti-
apoptotic role in neurulating chick embryos has been previously demonstrated [9], 
proinsulin may mediate other physiological effects in the precardiogenic area. Insulin 
receptor A isoform is expressed throughout cardiac development in mice and chicks, 
and can bind proinsulin with high affinity to predominantly activate mitogenic pathways 
[13]. We observed a deleterious effect on chick cardiogenesis when the physiological 
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decrease in proinsulin signaling was bypassed by forced expression of the most 
translationally active transcript, Pro1A, or the intermediate active transcript, Pro1B. 
These effects were accompanied by significant alterations in the expression of atrial and 
ventricular chamber genes. It is unlikely that increased proliferation or inhibition of 
apoptosis is implicated (preliminary results not shown). In view of the observed changes 
in Amhc1 and Vmhc1, particularly the lack of expression of Amhc1 in groups of cells 
(Fig. 5C) when proinsulin remains high, it is possible that proinsulin downregulation is 
part of the heart differentiation or morphogenetic program; further studies are required 
to investigate this hypothesis.  
A complex network of molecular signals modulates cardiac morphogenesis and 
cardiomyocyte differentiation during development [17]. Cardiac malformations in mice 
and humans have been reported in response to dysregulation of transcription factors and 
morphogenetic molecules [18]. As mentioned above, we recently reported that the 
catecholaminergic pathway initiated by early developmental expression of TH plays an 
important role in regulating the gene network involved in antero-posterior patterning of 
the primitive heart tube [10]. Thus molecules such as proinsulin and catecholamines, 
well known for their roles in other contexts in developed organisms, may play a 
regulatory role in early cardiogenesis. 
Understanding the impact of high proinsulin levels during development is clinically 
relevant, as there is a potential implication of proinsulin in fetal malformations in 
infants of obese and diabetic mothers. Maternal overweight and obesity are associated 
with an increased risk of fetal anomalies, including cardiac malformations [19, 20]. 
They could be additional factors to maternal hyperglycaemia contributing to that 
teratogenesis found in type 2 diabetes  [21]. Insulin resistance and beta cell dysfunction, 
typically associated with increased proinsulin/insulin concentrations [22, 23], are 
common to obesity and type 2 diabetes, and thus both proteins are potential teratogens. 
We wish to place the present results in the context of the malformations found more 
frequently in infants of diabetic and obese mothers and speculate that 
hyperproinsulinemia may contribute to the cardiac malformations in their infants. 
Further human studies, performed early in pregnancy, are required to test this 
hypothesis.  
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Figure Legends 
 
Figure 1. Expression of proinsulin mRNA transcripts in the developing chick 
heart. A) Schematic organization of the chick insulin gene and proinsulin mRNA 
transcript variants. The three exons (E) and two introns (I) of the insulin gene and 
primers for standard PCR are indicated. The right primer spans the exon 2-3 splicing 
junction. The Pro1B transcript exhibits a 5’ extension (clear grey box) as compared with 
the pancreatic transcript Pro1A. The Pro1B1 transcript resembles Pro1B but retains 
intron 1. B) RT-PCR for proinsulin mRNA transcripts in chick heart. RT was performed 
with RNA from pools of approximately 30-40 (stages 10 to 14) or 10-15 (stages 16 and 
20) hearts. C) Expression of proinsulin transcripts in the ventricular and atrial regions of 
the embryonic chick heart. Quantitative RT-PCR of RNA was performed from pools of 
9 ventricles and 9 atria from stage 12-13 hearts. The levels of each proinsulin transcript 
were normalized to GAPDH mRNA levels and the results expressed as a percentage 
with respect to the total (Pro1B+Pro1B1). A control (C) sample lacking cDNA is 
included in B. The PCR results were replicated several times with the same pools of 
hearts and once with another set of embryos. 
 
Figure 2. Expression of proinsulin mRNA transcripts in the developing mouse 
heart and pancreas A) Schematic organization of the insulin 2 gene, indicating the 
three exons (E) and two introns (I) and the primers used for standard PCR. B) RT-PCR 
for proinsulin mRNA transcripts in mouse heart. RT was performed with RNA from 
pools of hearts harvested at embryonic days (E) 8.5 (n = 24), E9.5 (n = 28), E10.5 (n = 
14), E12.5 (n = 14) and E13.5 (n = 7). The arrow indicates the fully spliced transcript 
and the arrowhead indicates the amplified band corresponding to unspliced intron 1 
isoform. The PCR results were replicated once. C) RT-PCR for proinsulin mRNA 
transcripts in mouse pancreas. RT was performed with RNA from pools of 4-8 
pancreas, except from E15.5-E16.5 stages when 2 pancreas were pooled. A control (C) 
sample lacking cDNA is included in B and C. 
Note that the intron 1 is 114 nt, slightly longer than the 102 nt reported by Minn et al. 
2005 [6], and we consider the initiation of transcription as mapped by Wentworth et al., 
1986 [24]. 
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Figure 3. Proinsulin translation levels after electroporation of whole chick 
embryos. Whole chick embryo lysates were resolved by SDS-PAGE and 
immunoblotted sequentially with three antibodies. The embryos had been collected 
directly from the incubated egg (in ovo) or after electroporation with plasmids (all were 
pCAGS-I-x-GFP) either control (GFP), pancreatic proinsulin-V5 transcript (Pro1AV5) 
or embryonic proinsulin-V5 transcripts (Pro1BV5). For this particular experiment, both 
proinsulin transcripts were fused to the V5 epitope to facilitate detection of the 
proinsulin protein. The anti-V5 recognizes the V5 tag linked to proinsulin which is not 
processed to insulin in the embryo. Anti-GFP immunoblotting indicates electroporation 
efficiency and anti-GAPDH  was used as a loading control. Note that Pro1BV5-
overexpressing embryos (lysates 1 and 2 from two different embryos) displayed much 
lower proinsulin levels than the Pro1AV5-overexpressing embryo lysate, despite their 
higher (sample 1) or similar (sample 2) GFP levels.  The blot shown is representative of 
three experiments. 
 
 
Figure 4. Expression of insulin receptor transcripts in the developing heart. 
RT-PCR for insulin receptor (IR) transcripts in embryonic chick (A) and mouse (B) 
hearts. A control (C) sample lacking cDNA is included. RT-PCR was performed with 
RNA from pools of hearts as described in the legend to Fig. 1 for chick; for mouse 
embryos, pools of 20-28 hearts (E8.5-E11.5) or 10-15 hearts (E12.5-E15.5) were used. 
Note that the two spliced mRNA variants of the mouse insulin receptor (IRA and IRB, 
arrowheads) were expressed at all embryonic stages analyzed in mice, while only one 
form of IR (corresponding to the IRA isoform) exists in chicks.  
 
Figure 5. Proinsulin overexpression in chick embryos alters anterior-posterior 
heart tube patterning, resulting in cardiac malformations. A) Representative light 
microscopy images of proinsulin (pCAGs-Proinsulin-I-GFP)-electroporated chick 
embryos  (three examples) exhibiting cardiac malformations, compared with a control 
GFP (pCAGs-I-GFP)-electroporated embryo. The shape of the heart tube is outlined 
with yellow dots. B) Whole-mount ISH for Amhc1 and Vmhc1 in electroporated chick 
embryos. GFP fluorescence images of the same embryos are shown in the 
corresponding panels on the left. The normal limit of Vmhc1 expression is outlined with 
yellow dots. On the isolated panel on the right, double ISH showing normal expression 
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of Vmhc1 (red) and Amhc1 (purple) in a stage 12 embryo. C) Whole-mount and sections 
of ISH for Amhc1 of proinsulin (pCAGs-Pro1B-I-GFP)-electroporated chick embryos 
(two different embryos), compared with a control GFP (pCAGs-I-GFP)-electroporated 
embryo. The black dotted line indicates the level of the histological section shown 
below each panel. In these sections, viewed by optical microscopy (20x objective), the 
discontinuity of the expression of Amhc1 in the more central located cells of the heart 
tube is evident. The selected embryos are representative of three to six per group 
subjected to ISH after electroporation. D) Schematic showing the proposed effect of 
proinsulin overexpression on atrio-ventricular markers in the developing chick heart.  
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Materials and Methods  
Embryos and plasmid electroporation  
All protocols for animal experiments were in accordance with EU guidelines for 
animal research and were approved by the CIB bioethics committee. Fertilized chicken 
eggs (Granja Santa Isabel, Córdoba, Spain) were incubated at 38ºC in forced-draft, 
humidified incubators. Embryos were staged according to [1], and cultured as described 
previously [2]. Mouse embryos (C57BL/6 and CD1) were removed from the uterus of 
pregnant females. The day of detection of the vaginal plug was designated as embryonic 
day (E) 0.5.  
For gain-of-function experiments, stage 3 cultured chick embryos were injected 
with pCAGs-I-GFP (control),  pCAGs-Pro1A-I-GFP or pCAGs-Pro1B-I-GFP in the 
region committed to form the heart and electroporated as described previously [2]. After 
an additional 28-36 hours of incubation (stage 11-12), embryos were either fixed in 4% 
PFA and processed for whole-mount ISH or collected for protein assay by Western blot 
following standard procedures. For proinsulin Western blot, the pCAGs-I-GFP 
(control), pCAGs-Pro1AV5-I-GFP or pCAGs-Pro1BV5-I-GFP vectors were 
electroporated into chick embryos. 
Whole-mount ISH and double ISH 
Whole-mount ISH was performed using digoxigenin-labelled chick Amhc1 and 
Vmhc1 probes, as previously described [2]. Double whole-mount ISH was performed 
using digoxigenin-labelled chick Amhc1 and fluorescein-labelled Vmhc1 (Roche) 
probes, as described [3], with some modifications. The addition of 1 μg/ml of both 
probes was followed by overnight incubation at the appropriate hybridization 
temperature. Embryos were then processed until the desired staining intensity for 
Amhc1 was achieved as described [2], and subsequently fixed. The fixative was 
removed and the embryos washed at room temperature in PBT (2 x 30 min) followed by 
MABT (2 x 30 min), in MABT at 63ºC (1 x 30 min), and again in MABT at room 
temperature (2 x 30 min). For fluorescein detection, nonspecific binding was blocked by 
incubation in blocking solution (2 x 1 hr) and the embryos were incubated overnight at 
4°C, with agitation, with AP-conjugated anti-fluorescein antibody (1:500 in blocking 
solution; Roche). The embryos were then washed at room temperature in MABT (6 x 1 
hr, followed by overnight incubation), and finally rinsed (2 x 20 min) in TBST (100 
mM Tris-HCl [pH 8.2-8.5], 0.25% Tween 20). AP-conjugated anti-fluorescein antibody 
was detected using the Vector Red Alkaline Phosphatase Substrate Kit I (Vector 
Laboratories) in TBST. The reaction was stopped by washing in PBT once the desired 
staining intensity for Vmhc1 was achieved, and the embryos were fixed in 4% PFA 
overnight and photographed. Selected embryos were embedded in paraffin, sectioned 
(14 µm), mounted and photographed under optical microscopy. 
RNA isolation and standard and quantitative PCR 
Total RNA from the whole heart or dissected heart regions and from the pancreas 
was isolated with the Trizol reagent (Invitrogen) and 2.5 µg of RNA was typically 
reverse transcribed (RT) using the Superscript III Kit and random primers (all from 
Invitrogen). Quantitative PCR (qPCR) was performed with the ABI Prism 7900HT 
Sequence Detection System (Applied Biosystems, Weiterstadt, Germany) using 
TaqMan Universal PCR Master Mix, No-AmpErase UNG (Applied Biosystems) and 
probes from the Universal Probe Library (URL, Roche Applied Science) for detection. 
Chick (c) and mouse (m) primer sequences and the respective URL probes are listed 
below.  
 Primers and URL probes for qRT-PCR: 
Gene Primers URL  
cPro1B GCAAACTTCTCTGCATCTCTTTCT (left) 136  
CCAGAAGAGGCAGTGATCG (right) 
cPro1B1 TGGTAAAGAGCTGGCTTGGT (left) 72 
GCAATGTGCTCAAAGACCTG (right) 
cGapdh  GTCCTCTCTGGCAAAGTCCA (left) 49 
ACCATGTAGTTCAGATCGATGAAG (right) 
Primers for standard RT-PCR: 
Gene Primers 
cIns GAATGGGGAAATTTCTACCAGT (left) 
 GACTGCTCACTAGGGGCTGC (right) 
cIR TGAGAGTGCAGAGGAGCAGA (left) 
 GGCACTGACATAAGCTGCAA (right) 
mIns2 TAACTGATCCGCTACAATCA (left) 
 CAGTAGTTCTCCAGCTGGTA (right) 
mIR GGCCAGTGAGTGCTGCTCATGC (left) 
 TGTGGTGGCTGTCACATTCC (right) 
 2.4. Plasmids 
pCAGs-Pro1B-I-GFP, pCAGs-Pro1BV5-I-GFP, pCAGs-Pro1A-I-GFP and 
pCAGs-Pro1AV5-I-GFP were generated by excising the corresponding proinsulin 
cDNA from previously described constructs [4] and cloning them into the pCAGs-I-
GFP [5]. 
2.5. Western immunoblot 
Individual embryos were lysed in a buffer containing 50 mM Tris-HCl (pH 6.8), 
10% (v/v) glycerol, 2% (w/v) SDS, 10 mM DTT and 0.005% (w/v) bromophenol blue. 
Half total protein lysate from each embryo was resolved on a 15% SDS-PAGE gel and 
transferred to nitrocellulose membranes (Protran, Whatman). Membranes were treated 
with 5% non-fat dry milk, 0.05% Tween 20 in PBS for 1-2 h at room temperature (RT), 
and sequentially incubated overnight at 4ºC with primary antibodies against V5 
(1/1000) (Life Technologies); GFP (1/1000) (Clonthech); and GAPDH (1:20000, 
Abcam). Antibodies were detected with appropriate horseradish peroxidase-labeled 
secondary antibodies (Pierce) and visualized with the Super Signal West Pico 
chemiluminescent substrate (Pierce). GAPDH was used as protein loading control. 
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Figure 1S:  Scheme depicting chick (A) and mouse (B) embryo heart at the 
corresponding indicated stages of development.  Chronologically, the chick stage (st) 
20 corresponds to 3.0-3.5 days of incubation, and the mouse E13.5 stage to 13.5 days of 
embryonic development. Ventricular regions are colored in red and atrial regions in 
blue. The youngest age is not colored since chamber regions are not yet well defined. 
 
  
Figure 2S-cPro1B  
 
Figure 2S (cont.)-cPro1B1  
 
Figure 2S (cont.)-mIns2NAT 
  
 
 
 
 
 
 
 
 
Figure 2S (cont.)-mIns2SPV 
 
 
 
Figure 2S: Secondary structure predictions of chick and mouse proinsulin mRNA 
isoforms. The secondary RNA minimun free energy structures of the chick, cPro1B and 
cPro1B1, and the mouse, mNAT and mSPV, proinsulin 5' UTR were predicted by the 
RNAfold program (Vienna RNA Package, http://www.tbi.univie.ac.at/~ivo/RNA/). 
Their resulting connect (.ct) format files were displayed by the Structure Display 
application from the mfold web server (http://mfold.rna.albany.edu/?q=mfold/Structure-
display-and-free-energy-determination) using its default parameters. 
Note that in the mouse insulin 2 gene, intron 1 is depicted with 114 nt, slightly longer 
than the 102 nt reported by Minn et al. 2005 [6], and we consider the initiation of 
transcription as mapped by Wentworth et al., 1986 [7]. Curved arrows point to the AUG 
translation initiation codon. 
  
 Table 1S 
Construction:                  pCAGS-I-GFP       pCAGs-Pro1A-I-GFP     pCAGs-Pro1B-I-GFP                          
Total malformed embryos 5/62 (8%)            22/36 (61%)                 8/20 (40%)  
Major malformation           0/62                     14/36                             0/20   
       Lack of endocardial  
       tubes fusion                     0/62                     10/36                             0/20 
Minor malformation           5/62                      8/36                              8/20  
    Altered anterior region      3/62                      6/36                              6/20 
  Major malformation: embryos in which heart tube formation failed to occur, some 
cases with lack of fusion of the two endocardial tubes into a single tube, or in which an 
aberrant non-beating heart tube was observed.  
 Minor malformation: embryos in which an abnormal but beating heart tube was 
observed.  In these cases, the predominantly affected region was the anterior (future 
ventricle and outer flow tract) part.  
 
 
